Itau Unibanco Holding S.A. Eagle Pharmaceuticals, Inc. Transaction History

Itau Unibanco Holding S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$43.24 - $55.02 $64,643 - $82,254	-1,495 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$34.37 - $60.07 $25,674 - $44,872	-747 Reduced 33.32%	1,495 $69,000
Q4 2019 Feb 14, 2020	BUY	$54.32 - $64.31 $121,785 - $144,183	2,242 New	2,242 $135,000
Q4 2018 Feb 13, 2019	SELL	$36.72 - $67.73 $57,356 - $105,794	-1,562 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$66.65 - $83.86 $8,531 - $10,734	128 Added 8.93%	1,562 $108,000
Q2 2018 Aug 13, 2018	BUY	$51.25 - $76.62 $73,492 - $109,873	1,434 New	1,434 $108,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.